We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COTY icon
251
Coty
COTY
$2.35B
$5.84M 0.09%
890,454
+213,611
+32% +$1.97M
MCHP icon
252
Microchip Technology
MCHP
$42.3B
$5.79M 0.09%
160,894
+98,986
+160% +$3.5M
GGAL icon
253
Galicia Financial Group
GGAL
$7.99B
$5.76M 0.09%
+209,000
New +$5.31M
VFC icon
254
VF Corp
VFC
$6.7B
$5.75M 0.09%
85,536
-1,504
-2% -$115K
FOLD
255
DELISTED
Amicus Therapeutics
FOLD
$5.71M 0.09%
596,000
+65,000
+12% +$714K
RIGL icon
256
Rigel Pharmaceuticals
RIGL
$707M
$5.7M 0.09%
247,800
+21,000
+9% +$593K
CMA
257
DELISTED
Comerica
CMA
$5.67M 0.09%
82,513
+28,216
+52% +$2.24M
MLM icon
258
Martin Marietta Materials
MLM
$34.3B
$5.62M 0.09%
32,702
-88
-0.3% -$15.6K
OXY icon
259
Occidental Petroleum
OXY
$55.2B
$5.61M 0.09%
91,399
-48,661
-35% -$3.42M
CNI icon
260
Canadian National Railway
CNI
$78B
$5.56M 0.09%
75,102
+12,569
+20% +$1.04M
PSX icon
261
Phillips 66
PSX
$83.5B
$5.51M 0.08%
64,005
-6,006
-9% -$587K
PCG icon
262
PG&E
PCG
$47.1B
$5.5M 0.08%
231,396
+21,565
+10% +$772K
EWC icon
263
iShares MSCI Canada ETF
EWC
$6.12B
$5.49M 0.08%
229,070
-3,596
-2% -$94.9K
BN icon
264
Brookfield
BN
$103B
$5.46M 0.08%
399,406
-252,061
-39% -$3.76M
CME icon
265
CME Group
CME
$92.1B
$5.46M 0.08%
29,001
-213
-0.7% -$39.3K
MRSH
266
Marsh
MRSH
$87.7B
$5.39M 0.08%
67,536
+3,345
+5% +$279K
BCE icon
267
BCE
BCE
$19.9B
$5.38M 0.08%
136,365
+18,043
+15% +$739K
TGT icon
268
Target
TGT
$63.7B
$5.37M 0.08%
81,227
-2,098
-3% -$161K
CERN
269
DELISTED
Cerner Corp
CERN
$5.32M 0.08%
101,357
-66,338
-40% -$3.85M
CLVS
270
DELISTED
Clovis Oncology, Inc.
CLVS
$5.26M 0.08%
293,100
+76,000
+35% +$1.55M
AVA icon
271
Avista
AVA
$3.45B
$5.21M 0.08%
+122,700
New +$6.08M
BNS icon
272
Scotiabank
BNS
$106B
$5.21M 0.08%
104,553
+5,872
+6% +$317K
PLD icon
273
Prologis
PLD
$137B
$5.17M 0.08%
88,103
+2,819
+3% +$183K
XRAY icon
274
Dentsply Sirona
XRAY
$2.63B
$5.16M 0.08%
138,762
+77,924
+128% +$2.84M
LEA icon
275
Lear
LEA
$7.24B
$5.16M 0.08%
42,011
-30,046
-42% -$4.02M
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.